• On June 27, 2026, McEwen Inc. (NYSE:MUX) was added to a broad suite of Russell indexes, including the Russell 2000, 2500, 3000, and related growth and value benchmarks, as part of the annual Russell Reconstitution.
• This extensive index inclusion materially broadens McEwen’s exposure to institutional and passive investors, potentially deepening liquidity and embedding the stock across multiple small-cap and style-based portfolios.
• With McEwen now embedded across key Russell indexes, we’ll explore how this expanded index presence interacts with its long-term copper and precious metals investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

McEwen Investment Narrative Recap

To own McEwen today, you need to believe in its copper and precious metals pipeline translating into sustainable cash generation, despite project and permitting complexity. The broad Russell index additions mainly affect who holds the stock rather than what the mines produce, so they do not fundamentally change the core near term catalyst around advancing Los Azules and Fox Complex, or the key risk of cost overruns, delays and potential funding needs across these development projects.

Among recent announcements, the Grey Fox pre feasibility study stands out in this context, because it directly underpins the Fox Complex life extension that many investors view as a nearer term production and cash flow driver. In contrast, the Russell inclusions speak more to liquidity and visibility, which may influence trading and ownership patterns around the time Grey Fox, Tartan and other projects hit critical permitting or capital decision milestones.

Yet, while index inclusion may seem like a clear positive, investors should also be aware of the risk that...

McEwen's narrative projects $631.8 million revenue and $350.0 million earnings by 2029.

Uncover how McEwen's forecasts yield a $32.10 fair value, a 79% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts painted a sharply different picture, assuming revenue could still grow about 50 percent annually to roughly US$565 million, but with far more conservative expectations around how efficiently that growth might convert into earnings. Against the backdrop of McEwen’s wide Russell index inclusion, their more cautious stance on execution at projects like Grey Fox suggests the market’s view on risk and reward could shift meaningfully as new data comes through.

Explore 8 other fair value estimates on McEwen - why the stock might be a potential multi-bagger!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your McEwen research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free McEwen research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate McEwen's overall financial health at a glance.

Curious About Other Options?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.